HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sabine Heublein Selected Research
Sabine Heublein Research Topics
Disease
22
Neoplasms (Cancer)
04/2022 - 10/2012
14
Breast Neoplasms (Breast Cancer)
08/2021 - 05/2013
13
Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 10/2012
8
Carcinoma (Carcinomatosis)
04/2022 - 12/2012
5
Neoplasm Metastasis (Metastasis)
01/2022 - 04/2014
4
Endometriosis
01/2022 - 11/2012
3
Carcinogenesis
08/2020 - 10/2012
3
Endometrial Neoplasms (Endometrial Cancer)
10/2019 - 12/2013
3
Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2018 - 02/2014
3
Ovarian Epithelial Carcinoma
08/2014 - 10/2012
2
Lymphatic Metastasis
11/2014 - 04/2014
2
Ovarian Diseases (Ovarian Disease)
12/2012 - 10/2012
1
Vulvar Neoplasms (Vulvar Cancer)
01/2022
1
Turcot syndrome
01/2022
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2019
1
Colorectal Neoplasms (Colorectal Cancer)
01/2018
1
Granulosa Cell Tumor
08/2014
1
Lobular Carcinoma
04/2014
1
Ductal Carcinoma
04/2014
1
Inflammation (Inflammations)
03/2013
1
Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases)
11/2012
Drug/Important Bio-Agent (IBA)
9
Estrogen Receptors
IBA
11/2021 - 11/2012
7
GTP-Binding Proteins (G-Protein)
IBA
11/2021 - 11/2012
5
Proteins (Proteins, Gene)
FDA Link
04/2022 - 01/2019
5
Estrogens (Estrogen)
FDA Link
01/2021 - 11/2012
5
Mucin-1 (CA 15-3 Antigen)
IBA
01/2020 - 10/2012
5
Antibodies
IBA
01/2019 - 10/2012
5
Hormones (Hormone)
IBA
01/2017 - 11/2012
4
Biomarkers (Surrogate Marker)
IBA
01/2022 - 10/2012
4
Epitopes
IBA
02/2020 - 01/2013
3
Protein Isoforms (Isoforms)
IBA
08/2020 - 10/2012
3
Thyroid Hormone Receptors (Thyroid Hormone Receptor)
IBA
08/2020 - 01/2015
3
FSH Receptors (FSH Receptor)
IBA
10/2019 - 01/2013
3
Antigens
IBA
10/2018 - 05/2013
2
Thomsen-Friedenreich antigen
IBA
02/2020 - 05/2013
2
MicroRNAs (MicroRNA)
IBA
06/2019 - 01/2018
2
Estrogen Receptor alpha
IBA
01/2018 - 02/2014
2
Carbohydrates
IBA
06/2016 - 10/2012
2
Cadherins (E-Cadherin)
IBA
11/2014 - 07/2013
2
hydrogen sulfite (bisulfite)
IBA
10/2014 - 02/2014
2
DNA (Deoxyribonucleic Acid)
IBA
10/2014 - 02/2014
2
Gonadotropins
IBA
08/2014 - 01/2013
2
Glycodelin
IBA
12/2013 - 10/2012
1
taxane
IBA
04/2022
1
Platinum
IBA
04/2022
1
Thyroid Hormone Receptors beta (TR beta)
IBA
02/2022
1
Chromatin
IBA
01/2022
1
Small Interfering RNA (siRNA)
IBA
11/2021
1
Lysine (L-Lysine)
FDA Link
11/2021
1
Histones (Histone)
IBA
11/2021
1
histone H3 trimethyl Lys4
IBA
11/2021
1
Thomsen-Friedenreich antibodies
IBA
02/2020
1
human ERBB2 protein
IBA
01/2020
1
Galectin 1 (LGALS1)
IBA
10/2019
1
Prostaglandins
IBA
10/2019
1
Type 4 Fibroblast Growth Factor Receptor
IBA
09/2019
1
Indicators and Reagents (Reagents)
IBA
07/2019
1
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
06/2019
1
tetraiodothyroacetic acid (TA(4))
IBA
01/2019
1
Thyroid Hormones
IBA
01/2019
1
Triiodothyronine (Liothyronine)
FDA Link
Generic
01/2019
1
thyronamine
IBA
01/2019
1
Oncogene Proteins (Oncogene Protein)
IBA
10/2018
1
Selective Estrogen Receptor Modulators (SERM)
IBA
01/2018
1
Raloxifene Hydrochloride (Evista)
FDA Link
01/2018
1
alpha-tocopherol transfer protein
IBA
05/2017
1
2,2'-azobis(2-amidinopropane) (ABAP)
IBA
05/2017
1
Retinoid X Receptors (Retinoid X Receptor)
IBA
01/2017
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
01/2017
1
Calcitriol Receptors (Calcitriol Receptor)
IBA
01/2017
1
Glycosyltransferases
IBA
08/2015
1
Surface Antigens (Surface Antigen)
IBA
05/2015
1
Cathepsin D
IBA
04/2014
1
Peptide Hydrolases (Proteases)
FDA Link
04/2014
1
Tumor Biomarkers (Tumor Markers)
IBA
04/2014
1
Cathepsins
IBA
04/2014
1
Biological Products
IBA
12/2013
1
Glycoproteins (Glycoprotein)
IBA
07/2013
1
Catenins
IBA
07/2013
1
PankoMab-GEX
IBA
01/2013
1
LH Receptors (LH Receptor)
IBA
01/2013
1
Steroids
IBA
11/2012
1
Progesterone
FDA Link
Generic
11/2012
1
progesterone receptor B
IBA
11/2012
1
N 30
IBA
11/2012
1
Peptides (Polypeptides)
IBA
10/2012
1
Gonadotropin Receptors
IBA
10/2012
Therapy/Procedure
3
Drug Therapy (Chemotherapy)
04/2022 - 10/2014
3
Therapeutics
06/2019 - 01/2015
2
Neoadjuvant Therapy
04/2022 - 12/2020
1
Lymph Node Excision (Lymph Node Dissection)
01/2022
1
Adjuvant Radiotherapy
01/2022
1
Adjuvant Chemotherapy
12/2020